IQVIA Holdings Inc. reported a revenue increase of 5.3% for the second quarter of 2025, reaching $4.017 billion compared to $3.814 billion in the same period of 2024. For the first half of 2025, revenues rose by 3.9% to $7.846 billion from $7.551 billion year-over-year. The company's net income for the second quarter was $266 million, down from $363 million in the prior year, resulting in diluted earnings per share of $1.54, compared to $1.97 in the same quarter of 2024. The decline in profitability was attributed to increased costs, particularly in the cost of revenues, which rose to $2.694 billion from $2.488 billion in the previous year.
In terms of operational performance, IQVIA's Technology & Analytics Solutions segment saw a notable revenue increase of 8.9% in the second quarter, totaling $1.628 billion, while the Research & Development Solutions segment grew by 2.5% to $2.201 billion. The Contract Sales & Medical Solutions segment also experienced growth, with revenues increasing by 9.3% to $188 million. The company reported a total of approximately 90,000 employees across more than 100 countries, reflecting its extensive operational footprint.
Strategically, IQVIA has continued to focus on acquisitions and restructuring efforts to enhance operational efficiency. The company completed several immaterial acquisitions during the first half of 2025, contributing to an increase in goodwill, which rose to $15.611 billion from $14.710 billion at the end of 2024. Additionally, restructuring costs increased to $61 million for the first half of 2025, up from $43 million in the same period of 2024, as the company aims to streamline operations and adapt to market conditions.
The company also reported a significant increase in cash and cash equivalents, which rose to $2.039 billion as of June 30, 2025, compared to $1.702 billion at the end of 2024. This increase was driven by cash generated from operations and financing activities, including the issuance of $2 billion in senior notes. Looking ahead, IQVIA anticipates continued revenue growth, with approximately $34.6 billion in future performance obligations expected to be recognized, indicating a strong pipeline for the coming years. The company remains committed to leveraging its data and analytics capabilities to drive innovation in the healthcare sector.
About IQVIA HOLDINGS INC.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.